Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Validation of an algorithm for identifying MS cases in administrative health claims datasets.

Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG; United States Multiple Sclerosis Prevalence Workgroup (MSPWG).

Neurology. 2019 Mar 5;92(10):e1016-e1028. doi: 10.1212/WNL.0000000000007043. Epub 2019 Feb 15.

PMID:
30770432
2.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.

PMID:
30770430
3.

A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.

Nelson LM, Wallin MT, Marrie RA, Culpepper WJ, Langer-Gould A, Campbell J, Buka S, Tremlett H, Cutter G, Kaye W, Wagner L, Larocca NG; United States Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):469-480. doi: 10.1212/WNL.0000000000007044. Epub 2019 Feb 15. Review.

PMID:
30770422
4.

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.

Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N, Hudson LD, Rudick RA, LaRocca NG; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct 18:1352458518808204. doi: 10.1177/1352458518808204. [Epub ahead of print]

PMID:
30334474
5.

Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce.

Halpern MT, Kane H, Teixeira-Poit S, Ford C, Giesser B, Halper J, Johnson S, LaRocca NG, Miller A, Ringel SP.

Int J MS Care. 2018 Jan-Feb;20(1):35-43. doi: 10.7224/1537-2073.2016-044.

6.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct;24(11):1469-1484. doi: 10.1177/1352458517723718. Epub 2017 Aug 11.

7.

Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities.

Motl RW, Mowry EM, Ehde DM, LaRocca NG, Smith KE, Costello K, Shinto L, Ng AV, Sullivan AB, Giesser B, McCully KK, Fernhall B, Bishop M, Plow M, Casaccia P, Chiaravalloti ND.

Mult Scler. 2018 Mar;24(3):262-267. doi: 10.1177/1352458516687404. Epub 2017 Jan 12.

8.

Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Larocca NG.

Patient. 2011;4(3):189-201. doi: 10.2165/11591150-000000000-00000.

PMID:
21766914
9.

Preface: Perspectives of an MS Researcher.

Larocca NG.

Occup Ther Health Care. 2004;17(3-4):xix-xx. doi: 10.1080/J003v17n03_b. No abstract available.

PMID:
23941227
10.

Minimal neuropsychological assessment of MS patients: a consensus approach.

Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM, Munschauer F.

Clin Neuropsychol. 2002 Aug;16(3):381-97. Review.

PMID:
12607150
11.

Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness.

Shawaryn MA, Schiaffino KM, LaRocca NG, Johnston MV.

Mult Scler. 2002 Aug;8(4):310-8.

PMID:
12166502
12.

Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis.

Foley FW, LaRocca NG, Sanders AS, Zemon V.

Mult Scler. 2001 Dec;7(6):417-21.

PMID:
11795465
13.

Recent developments in the assessment of quality of life in multiple sclerosis (MS).

Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H, Paty D.

Mult Scler. 1999 Aug;5(4):251-9. Review.

PMID:
10467384
14.

Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury.

Shnek ZM, Foley FW, LaRocca NG, Gordon WA, DeLuca J, Schwartzman HG, Halper J, Lennox S, Irvine J.

Ann Behav Med. 1997 Summer;19(3):287-94.

PMID:
9603703
15.

A program to facilitate retention of employment among persons with multiple sclerosis.

Larocca NG, Kalb RC, Gregg K.

Work. 1996;7(1):37-46. doi: 10.3233/WOR-1996-7106.

PMID:
24441620
16.

Stress, Multiple Sclerosis, and Everyday FunctioningA Review of the Literature with Implications for Intervention.

Foley FW, Larocca NG, Kalb RC, Caruso LS, Shnek Z.

NeuroRehabilitation. 1993;3(4):57-66. doi: 10.3233/NRE-1993-3409.

PMID:
24526157
17.

Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.

Larocca NG, Kalb RC, Foley FW, McGann CM.

NeuroRehabilitation. 1993;3(4):30-8. doi: 10.3233/NRE-1993-3406.

PMID:
24526154
18.

Endogenous event-related potentials as indices of dementia in multiple sclerosis patients.

Giesser BS, Schroeder MM, LaRocca NG, Kurtzberg D, Ritter W, Vaughan HG, Scheinberg LC.

Electroencephalogr Clin Neurophysiol. 1992 May;82(5):320-9.

PMID:
1374701
19.

A prospective study of depression and immune dysregulation in multiple sclerosis.

Foley FW, Traugott U, LaRocca NG, Smith CR, Perlman KR, Caruso LS, Scheinberg LC.

Arch Neurol. 1992 Mar;49(3):238-44.

PMID:
1536625
20.

High-dose oral baclofen: experience in patients with multiple sclerosis.

Smith CR, LaRocca NG, Giesser BS, Scheinberg LC.

Neurology. 1991 Nov;41(11):1829-31.

PMID:
1944915
21.

A study of fatigue in systemic lupus erythematosus.

Krupp LB, LaRocca NG, Muir J, Steinberg AD.

J Rheumatol. 1990 Nov;17(11):1450-2.

PMID:
2273484
22.

Guidelines for neuropsychological research in multiple sclerosis.

Peyser JM, Rao SM, LaRocca NG, Kaplan E.

Arch Neurol. 1990 Jan;47(1):94-7. Review.

PMID:
2403789
23.

Multiple sclerosis program: a model for neuropsychiatric disorders.

LaRocca NG, Hall HL.

New Dir Ment Health Serv. 1990 Spring;(45):49-64. Review. No abstract available.

PMID:
2191214
24.

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD.

Arch Neurol. 1989 Oct;46(10):1121-3.

PMID:
2803071
25.

A comparative study of impairment ratings in multiple sclerosis patients.

Holland NJ, Francabandera F, Wiesel-Levison P, Halper J, LaRocca NG, Scheinberg LC.

Rehabil Nurs. 1988 Sep-Oct;13(5):244-50. No abstract available.

PMID:
3187174
26.

Fatigue in multiple sclerosis.

Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC.

Arch Neurol. 1988 Apr;45(4):435-7.

PMID:
3355400
27.

Psychoimmunological dysregulation in multiple sclerosis.

Foley FW, Miller AH, Traugott U, LaRocca NG, Scheinberg LC, Bedell JR, Lennox SS.

Psychosomatics. 1988 Fall;29(4):398-403. No abstract available.

PMID:
2906448
28.

Efficacy of stress-inoculation training in coping with multiple sclerosis.

Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M.

J Consult Clin Psychol. 1987 Dec;55(6):919-22. No abstract available.

PMID:
3693660
29.

Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of multiple sclerosis.

Giesser BS, Kurtzberg D, Vaughan HG Jr, Arezzo JC, Aisen ML, Smith CR, LaRocca NG, Scheinberg LC.

Arch Neurol. 1987 Mar;44(3):281-4.

PMID:
3827679
30.

Development and testing of a minimal record of disability in multiple sclerosis.

Slater RJ, LaRocca NG, Scheinberg LC.

Ann N Y Acad Sci. 1984;436:453-68. No abstract available.

PMID:
6598023
31.

Psychosocial factors in multiple sclerosis and the role of stress.

LaRocca NG.

Ann N Y Acad Sci. 1984;436:435-42. No abstract available.

PMID:
6598021
32.

Development of a structured interview to accompany the minimal record.

LaRocca NG, Foley F.

Acta Neurol Scand Suppl. 1984;101:165-8.

PMID:
6594908
33.

Experience in the use of the Minimal Record of Disability in multiple sclerosis chapters and community settings.

Madonna MG, Hannah B, LaRocca NG.

Acta Neurol Scand Suppl. 1984;101:139-42.

PMID:
6594903
34.

Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada.

LaRocca NG, Scheinberg LC, Slater RJ, Giesser B, Smith CR, Traugott U, Schapiro RT, Paty DW, Franklin GM, Cobble N, et al.

Acta Neurol Scand Suppl. 1984;101:126-38.

PMID:
6594902
35.

The cost-effectiveness of multiple sclerosis rehabilitation: a model.

Feigenson JS, Scheinberg L, Catalano M, Polkow L, Mantegazza PM, Feigenson WD, LaRocca NG.

Neurology. 1981 Oct;31(10):1316-22.

PMID:
6810201

Supplemental Content

Loading ...
Support Center